FEDERICO MAESE
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease RED OAK, TX NPI 1922123728
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease TX Amgen Inc. All categories
General Payments — all program years on this page
$3,397.33
- Category: General Payments
- Program years: PY2018–2024
- Record count: 94
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $384.39 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $309.40 | 7 |
| Education | $74.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $156.15 | 4 |
| Siemens Medical Solutions USA, Inc. | $113.75 | 1 |
| Acerta Pharma LLC | $74.99 | 1 |
| Novo Nordisk AS | $24.58 | 1 |
| Philips Electronics North America Corporation | $14.92 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1093684226 | Siemens Medical Solutions USA, Inc. | $113.75 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096667370 | Novo Nordisk Inc | $24.58 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104316674 | AstraZeneca Pharmaceuticals LP | $74.99 | 03/08/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1111640318 | Amgen Inc. | $9.94 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111640320 | Amgen Inc. | $9.14 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111640322 | Amgen Inc. | $8.82 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111640324 | Amgen Inc. | $128.25 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146847234 | Philips North America LLC | $14.92 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.